Discrepancies between anti-Intereukin5 ( anti-IL5) starters from SHARP central registry and eligible patients in clinical trials

被引:0
|
作者
Principe, S. [1 ]
Richards, L. B. [1 ,2 ]
Hashimoto, S. [1 ,2 ]
Kroes, J. A. [3 ]
Van Bragt, J. J. [1 ,2 ]
Vijverberg, S. J. [1 ,2 ]
Sont, J. K. [4 ]
Scichilone, N. [2 ]
Bieksiene, K. [5 ]
Brinke, A. T. [6 ]
Csoma, Z. [7 ]
Dahlen, B. [8 ]
Gemicioglu, B. [9 ]
Grisle, I [10 ]
Kuna, P. [11 ]
Lazic, Z. [12 ]
Mihaltan, F. [13 ]
Popovic-Grle, S. [14 ]
Skgrat, S. [15 ]
Van der Zee, A. Maitland [1 ,2 ]
机构
[1] Univ Amsterdam, Dept Resp Med, Med Ctr, Amsterdam, Netherlands
[2] Univ Palermo, Dept Pulmonol, AOUP Policlin Paolo Giaccone, Palermo, Italy
[3] Med Ctr Leeuwarden, Dept Clin Pharm & Pharmacol, Leeuwarden, Netherlands
[4] Leiden Univ, Dept Biomed Data Sci, Sect Med Decis Making, Med Ctr, Leiden, Netherlands
[5] Lithuanian Univ Hlth Sci, Dept Pulmonol, Kaunas, Lithuania
[6] Med Ctr Leeuwarden, Leeuwarden, Netherlands
[7] Natl Koranyi Inst Pulmonol, Budapest, Hungary
[8] Karolinska Inst, Stockholm, Sweden
[9] Istanbul Univ Cerrahpasa, Cerrahpasa Fac Med, Dept Pulm Dis, Istanbul, Turkey
[10] Riga East Univ Hosp, Riga, Latvia
[11] Med Univ Lodz, Lodz, Poland
[12] Univ Clin Ctr Kragujevac, Kragujevac, Serbia
[13] Natl Inst Pneumol, Bucharest, Romania
[14] Univ Hosp Ctr Zagreb, KBCZ Clin Ctr Pulm Dis Jordanovac, Zagreb, Croatia
[15] Univ Ljubljana, Univ Med Ctr Ljubljana, Med Fac, Pulm Dept, Ljubljana, Slovenia
关键词
D O I
10.1183/13993003.congress-2022.2197
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
2197
引用
收藏
页数:2
相关论文
共 50 条
  • [11] Clinical and Lung Function Outcomes After Anti-IgE or Anti-IL5 Therapy in Severe Asthma
    AlShareef, Saad
    McDonald, Christine F.
    Lee, Joy
    JOURNAL OF ASTHMA AND ALLERGY, 2022, 15 : 209 - 217
  • [12] Patients eligible for anti-IL-5/anti-IL-5Ra treatment in a cohort of adult-onset asthma
    Ilmarinen, Pinja
    Tuomisto, Leena E.
    Niemela, Onni
    Kankaanranta, Hannu
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [13] Clinical Predictors of Treatment Failure to Anti-IL5 Therapy in Severe Eosinophilic Asthma
    Reihman, A. E.
    Liu, C.
    Cruse, M. H.
    Freid, L.
    Perez, N.
    Smith, V. L.
    Ferguson, L.
    Wechsler, M.
    Holguin, F.
    Manka, L.
    Sharma, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [14] Anti-IL5 and anti-IL5R-alpha Therapy in Patients with clinically significant Bronchiectasis and an eosinophilic Endotype: a retrospective Case Series
    Rademacher, J.
    Konwert, S.
    Fuge, J.
    Dettmer, S.
    Welte, T.
    Ringshausen, F. C.
    PNEUMOLOGIE, 2020, 74 : S7 - S7
  • [15] Reduction in FeNO on anti-IL5 biologics is associated with clinical remission of severe asthma
    Soendergaard, Marianne Baastrup
    Hansen, Susanne
    Haakansson, Kjell Erik Julius
    Von Bulow, Anna
    Bjerrum, Anne-Sofie
    Schmid, Johannes Martin
    Johnsen, Claus Rikard
    Hilberg, Ole
    Ulrik, Charlotte Suppli
    Porsbjerg, Celeste
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [16] The impact of anti-IL5 therapies on patients with severe eosinophilic asthma: a proteomic approach
    Cameli, P.
    Vantaggiato, L.
    D'Alessandro, M.
    Bergantini, L.
    Shaba, E.
    Carleo, A.
    Di Giuseppe, F.
    Angelucci, S.
    Bini, L.
    Bargagli, E.
    Landi, C.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [17] Arthritis, a new adverse effect of anti-IL5 biologics in severe asthma patients?
    Dupin, C.
    Morer, L.
    Phillips-Houlbracq, M.
    Deneuville, L.
    Lebrun, M.
    Tabeze, L.
    Juge, P.
    Taille, C.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [18] First Outcomes of Anti-IL5 Biological Therapy in Patients with Severe Asthma in Croatia
    Rnjak, D.
    Stajduhar, A.
    Popovic-Grle, S.
    Ferara, N.
    Jelavic, I
    Lampalo, M.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [19] Is FeNO a reliable marker for follow-up of patients on anti-IL5 therapy?
    Silva, Raquel Alexandra Dos Santos
    Simoes, Joana Marques
    Lopes, Carlos
    Cabrita, Henrique
    Manique, Alda
    Barbara, Cristina
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [20] Combining Biologic Therapies Involving Anti-IgE, Anti-IL5, Anti-IL5R and Anti IL-4/IL-13: Experience from a Large Academic Health System
    Pitlick, Mitchell
    Pongdee, Thanai
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB193 - AB193